Heat Biologics Stock Valuation

HTBX -  USA Stock  

USD 2.90  0.07  2.36%

Do you wonder what the value of Heat Biologics is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Heat Biologics, is its stock price multiplied by the total number of shares outstanding, calculating Heat Biologics' enterprise value requires a different approach. It uses Heat Biologics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Heat Biologics Enterprise Value is fairly stable at the moment as compared to the past year. Heat Biologics reported Enterprise Value of 114.31 Million in 2021. Tangible Asset Value is likely to rise to about 152.3 M in 2022, whereas Free Cash Flow is likely to drop (21.7 M) in 2022.
Heat Biologics retains a regular Real Value of $7.35 per share. The prevalent price of the firm is $2.9. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model calculates the value of Heat Biologics from evaluating the firm fundamentals such as return on asset of (13.53) %, and Return On Equity of (23.16) % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Heat Biologics Valuation 

 
Refresh
Heat Biologics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Heat Biologics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
2.90
19th of January 2022
Share
Please note that Heat Biologics' price fluctuation is slightly risky at this time. Calculation of the real value of Heat Biologics is based on 3 months time horizon. Increasing Heat Biologics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Heat Biologics is useful when determining the fair value of the Heat Biologics stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Heat Biologics. Since Heat Biologics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heat Biologics Stock. However, Heat Biologics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
7.35
Real Value
11.13
Upside
Estimating the potential upside or downside of Heat Biologics helps investors to forecast how Heat Biologics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heat Biologics more accurately as focusing exclusively on Heat Biologics' fundamentals will not take into account other important factors:
Earnings
Estimates (4)
LowProjected EPSHigh
-1.22-1.2-1.16
Details
Hype
Prediction
LowEstimated ValueHigh
0.163.196.97
Details
4 Analysts
Consensus
LowTarget PriceHigh
15.0020.8033.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Heat Biologics' intrinsic value based on its ongoing forecasts of Heat Biologics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Heat Biologics' closest peers. When choosing an evaluation method for Heat Biologics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Heat Biologics Investments

125.12 MillionShare

Heat Biologics Valuation Drivers Correlation

Many accounts on the financial statements of Heat Biologics are highly interrelated and sometimes correlated. Consequently, when conducting Heat Biologics's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Heat Biologics
Click cells to compare fundamentals

Heat Biologics Valuation Trend

Knowing Heat Biologics' actual value is paramount for traders to make sound investment determinations. Heat Biologics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Heat Biologics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Heat Biologics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Heat Biologics Market Cap

Heat Biologics is one of the top stocks in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 100.91 Million. Heat Biologics totals roughly 76.97 Million in market capitalization claiming about 76% of stocks in Biotechnology industry.
Capitalization  Workforce  Revenue  Total debt  Valuation

Heat Biologics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Heat Biologics's current stock value. Our valuation model uses many indicators to compare Heat Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heat Biologics competition to find correlations between indicators driving Heat Biologics's intrinsic value. More Info.
Heat Biologics is one of the top stocks in beta category among related companies. It is rated # 2 in price to sales category among related companies fabricating about  140.77  of Price to Sales per Beta. Price to Sales Ratio is likely to drop to 21.42 in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value Heat Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Heat Biologics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heat Biologics' earnings, one of the primary drivers of an investment's value.

About Heat Biologics Valuation

The equity valuation mechanism determines the current worth of Heat Biologics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Heat Biologics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Heat Biologics based exclusively on its fundamental and basic technical indicators. By analyzing Heat Biologics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Heat Biologics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heat Biologics. We calculate exposure to Heat Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Heat Biologics's related companies.
Last ReportedProjected for 2022
Gross Profit3.4 M3.4 M
Profit Margin(10.16) (10.96) 
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through T-cell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Heat Biologics Quarterly Enterprise Value

131.06 MillionShare

Heat Biologics Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Heat Biologics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio33.12
Revenue Growth-41.00%
Enterprise Value To Ebitda1.05
Enterprise Value To Revenue-13.97

Heat Biologics Current Valuation Indicators

Valuation refers to the process of determining the present value of Heat Biologics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Heat Biologics we look at many different elements of the entity such as Heat Biologics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Heat Biologics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Heat Biologics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Heat Biologics' worth.
Please check Risk vs Return Analysis. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Heat Biologics Stock analysis

When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Is Heat Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heat Biologics. If investors know Heat Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heat Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.